146 related articles for article (PubMed ID: 31357803)
21. Construction and verification of a novel circadian clock related long non-coding RNA model and prediction of treatment for survival prognosis in patients with hepatocellular carcinoma.
Zhang Z; Gao W; Tan X; Deng T; Zhou W; Jian H; Zeng P
BMC Cancer; 2023 Jan; 23(1):57. PubMed ID: 36647032
[TBL] [Abstract][Full Text] [Related]
22. Identification of a CD4+ conventional T cells-related lncRNAs signature associated with hepatocellular carcinoma prognosis, therapy, and tumor microenvironment.
Zhu L; Zhang XP; Xu S; Hu MG; Zhao ZM; Zhao GD; Xiao ZH; Liu R
Front Immunol; 2022; 13():1111246. PubMed ID: 36700197
[TBL] [Abstract][Full Text] [Related]
23. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
Fan CN; Ma L; Liu N
J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
[TBL] [Abstract][Full Text] [Related]
24. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis.
Shi XM; Teng F
Int J Clin Exp Pathol; 2015; 8(4):4008-14. PubMed ID: 26097588
[TBL] [Abstract][Full Text] [Related]
25. A disulfidptosis-related lncRNAs signature in hepatocellular carcinoma: prognostic prediction, tumor immune microenvironment and drug susceptibility.
Liu Y; Meng J; Ruan X; Wei F; Zhang F; Qin X
Sci Rep; 2024 Jan; 14(1):746. PubMed ID: 38185671
[TBL] [Abstract][Full Text] [Related]
26. A three-long non-coding RNA-expression-based risk score system can better predict both overall and recurrence-free survival in patients with small hepatocellular carcinoma.
Gu J; Zhang X; Miao R; Ma X; Xiang X; Fu Y; Liu C; Niu W; Qu K
Aging (Albany NY); 2018 Jul; 10(7):1627-1639. PubMed ID: 30018179
[TBL] [Abstract][Full Text] [Related]
27. The clinical significance and biological function of lncRNA RGMB-AS1 in hepatocellular carcinoma.
Sheng N; Li Y; Qian R; Li Y
Biomed Pharmacother; 2018 Feb; 98():577-584. PubMed ID: 29288973
[TBL] [Abstract][Full Text] [Related]
28. Identification of a RNA-Seq Based 8-Long Non-Coding RNA Signature Predicting Survival in Esophageal Cancer.
Fan Q; Liu B
Med Sci Monit; 2016 Dec; 22():5163-5172. PubMed ID: 28028307
[TBL] [Abstract][Full Text] [Related]
29. A potential prognostic lncRNA signature for predicting survival in patients with bladder urothelial carcinoma.
Bao Z; Zhang W; Dong D
Oncotarget; 2017 Feb; 8(6):10485-10497. PubMed ID: 28060759
[TBL] [Abstract][Full Text] [Related]
30. Eight key long non-coding RNAs predict hepatitis virus positive hepatocellular carcinoma as prognostic targets.
Huang ZL; Li W; Chen QF; Wu PH; Shen LJ
World J Gastrointest Oncol; 2019 Nov; 11(11):983-997. PubMed ID: 31798779
[TBL] [Abstract][Full Text] [Related]
31. Identification of long noncoding RNAs biomarkers in patients with hepatitis B virus-associated hepatocellular carcinoma.
Mou Y; Wang D; Xing R; Nie H; Mou Y; Zhang Y; Zhou X
Cancer Biomark; 2018; 23(1):95-106. PubMed ID: 29991128
[TBL] [Abstract][Full Text] [Related]
32. Discovery of a novel six-long non-coding RNA signature predicting survival of colorectal cancer patients.
Fan Q; Liu B
J Cell Biochem; 2018 Apr; 119(4):3574-3585. PubMed ID: 29227531
[TBL] [Abstract][Full Text] [Related]
33. Molecular subtypes and a prognostic model for hepatocellular carcinoma based on immune- and immunogenic cell death-related lncRNAs.
He M; Gu W; Gao Y; Liu Y; Liu J; Li Z
Front Immunol; 2022; 13():1043827. PubMed ID: 36479122
[TBL] [Abstract][Full Text] [Related]
34. Comprehensive analysis of a novel lncRNA profile reveals potential prognostic biomarkers in clear cell renal cell carcinoma.
Liu T; Sui J; Zhang Y; Zhang XM; Wu WJ; Yang S; Xu SY; Hong WW; Peng H; Yin LH; Pu YP; Liang GY
Oncol Rep; 2018 Sep; 40(3):1503-1514. PubMed ID: 30015930
[TBL] [Abstract][Full Text] [Related]
35. The prognostic value of an autophagy-related lncRNA signature in hepatocellular carcinoma.
Yang S; Zhou Y; Zhang X; Wang L; Fu J; Zhao X; Yang L
BMC Bioinformatics; 2021 Apr; 22(1):217. PubMed ID: 33910497
[TBL] [Abstract][Full Text] [Related]
36. An eight-lncRNA signature predicts survival of breast cancer patients: a comprehensive study based on weighted gene co-expression network analysis and competing endogenous RNA network.
Sun M; Wu D; Zhou K; Li H; Gong X; Wei Q; Du M; Lei P; Zha J; Zhu H; Gu X; Huang D
Breast Cancer Res Treat; 2019 May; 175(1):59-75. PubMed ID: 30715658
[TBL] [Abstract][Full Text] [Related]
37. Development and validation of a novel pseudogene pair-based prognostic signature for prediction of overall survival in patients with hepatocellular carcinoma.
Du Y; Gao Y
BMC Cancer; 2020 Sep; 20(1):887. PubMed ID: 32938429
[TBL] [Abstract][Full Text] [Related]
38. A 15-long non-coding RNA signature to improve prognosis prediction of cervical squamous cell carcinoma.
Mao X; Qin X; Li L; Zhou J; Zhou M; Li X; Xu Y; Yuan L; Liu QN; Xing H
Gynecol Oncol; 2018 Apr; 149(1):181-187. PubMed ID: 29525275
[TBL] [Abstract][Full Text] [Related]
39. Prognostic Value of a Long Non-coding RNA Signature in Localized Clear Cell Renal Cell Carcinoma.
Qu L; Wang ZL; Chen Q; Li YM; He HW; Hsieh JJ; Xue S; Wu ZJ; Liu B; Tang H; Xu XF; Xu F; Wang J; Bao Y; Wang AB; Wang D; Yi XM; Zhou ZK; Shi CJ; Zhong K; Sheng ZC; Zhou YL; Jiang J; Chu XY; He J; Ge JP; Zhang ZY; Zhou WQ; Chen C; Yang JH; Sun YH; Wang LH
Eur Urol; 2018 Dec; 74(6):756-763. PubMed ID: 30143382
[TBL] [Abstract][Full Text] [Related]
40. A three-lncRNA expression signature predicts survival in head and neck squamous cell carcinoma (HNSCC).
Wang P; Jin M; Sun CH; Yang L; Li YS; Wang X; Sun YN; Tian LL; Liu M
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30355656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]